Among the 18 patients with lymph node metastasis at nephroureterectomy who underwent retroperitoneal lymph node dissection and received adjuvant chemotherapy, the patients with higher Nrf2 expression in the primary tumor had worse recurrence-free survival. This evidence concerns the gene NFE2L2 and metastatic malignant neoplasm in the lymph nodes.